Itonis (Itonis) Insider Ownership : 9.38 % (As of May. 22, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Itonis Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Itonis's insider ownership is 9.38%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Itonis's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Itonis's Float Percentage Of Total Shares Outstanding is 0.00%.

Itonis Insider Ownership Historical Data

The historical data trend for Itonis's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis Insider Ownership Chart

Itonis Historical Data

The historical data trend for Itonis can be seen below:

	2009-05-31	2009-06-30	2009-07-31	2009-08-31	2009-09-30	2009-10-31	2009-11-30	2009-12-31	2010-01-31	2010-02-28
Insider Ownership	9.38	9.38	9.38	9.38	9.38	9.38	9.38	9.38	9.38	9.38

Itonis Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Itonis (Itonis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » Insider Ownership

Comparable Companies

FZMD SNYR SGMFF PMC EBOSF OMI UDHCF PBH PDCO SHPMY SHTDY HSIC ABC CAH MCK

Traded in Other Exchanges

N/A

Address

22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630

Website

http://www.itonisholdings.com

Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines

From GuruFocus

Itonis, Inc. announces “Emesyl® Plus” homeopathic nasal spray containing Premium Hemp Oil

By Marketwired Marketwired • 09-26-2018